title: Rimonabant during early pregnancy.
authors.affiliation: Département d'Obstétrique et Gynécologie, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Paris, France. g.ducarme@gmail.com
authors.forename: Guillaume
authors.initials: G
authors.lastname: Ducarme
authors.forename: Pierre-François
authors.initials: PF
authors.lastname: Ceccaldi
authors.forename: Hélène
authors.initials: H
authors.lastname: Pejoan
authors.forename: Dominique
authors.initials: D
authors.lastname: Luton
mesh_terms: D000328:Adult; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D010880:Piperidines / Q000009:adverse effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011256:Pregnancy Outcome; D011720:Pyrazoles / Q000009:adverse effects*; D000077285:Rimonabant
chemical_list: D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant